LC
DMAC icon

Leon Cooperman’s DiaMedica Therapeutics DMAC Stock Holding History

Leon Cooperman’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.3M Buy
3,450,000
+1,430,000
+71% +$8.79M 0.68% 27
2026
Q1 		$13.7M Hold
2,020,000
– – 0.45% 30
2025
Q4 		$16.1M Sell
2,020,000
-1,249,761
-38% -$9.35M 0.53% 30
2025
Q3 		$17.6M Buy
3,269,761
+1,619,761
+98% +$8.79M 0.55% 30
2025
Q2 		$6.43M Buy
1,650,000
+25,000
+2% +$97.5K 0.23% 31
2025
Q1 		$6.16M Hold
1,625,000
– – 0.24% 30
2024
Q4 		$8.82M Buy
1,625,000
+113,261
+7% +$534K 0.33% 30
2024
Q3 		$6.33M Buy
1,511,739
+111,739
+8% +$413K 0.27% 29
2024
Q2 		$4.13M Buy
1,400,000
+516,377
+58% +$1.42M 0.17% 32
2024
Q1 		$2.45M Hold
883,623
– – 0.1% 36
2023
Q4 		$2.51M Buy
883,623
+7,630
+0.9% +$18.9K 0.12% 36
2023
Q3 		$2.26M Hold
875,993
– – 0.12% 38
2023
Q2 		$3.78M Buy
875,993
+7,580
+0.9% +$18.4K 0.21% 34
2023
Q1 		$1.33M Buy
868,413
+55,905
+7% +$88.7K 0.08% 39
2022
Q4 		$1.28M Hold
812,508
– – 0.08% 40
2022
Q3 		$1.01M Hold
812,508
– – 0.07% 41
2022
Q2 		$1.64M Hold
812,508
– – 0.11% 38
2022
Q1 		$2.03M Buy
812,508
+512,508
+171% +$1.45M 0.11% 41
2021
Q4 		$1.12M Buy
300,000
+100,000
+50% +$393K 0.06% 49
2021
Q3 		$802K Buy
200,000
+150,000
+300% +$574K 0.04% 50
2021
Q2 		$223K Hold
50,000
– – 0.01% 62
2021
Q1 		$458K Buy
50,000
+20,000
+67% +$187K 0.03% 45
2020
Q4 		$304K Buy
+30,000
New +$164K 0.02% 43

Other funds holding DMAC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Leon Cooperman's DMAC Position: Q2 2026 in Review

Leon Cooperman increased its DiaMedica Therapeutics (DMAC) stake by 71% in Q2 2026, buying an estimated $8.79M and bringing the position to 3,450,000 shares worth $24.3M. The position accounts for 0.68% of the portfolio, ranked #27.

Leon Cooperman first reported a position in DMAC in Q4 2020 and has held it in 23 quarters since. 88 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • Leon Cooperman held 3,450,000 shares of DiaMedica Therapeutics worth $24.3M as of Q2 2026.
  • Leon Cooperman bought 1,430,000 DiaMedica Therapeutics shares in Q2 2026, an estimated $8.79M.
  • DiaMedica Therapeutics made up 0.68% of Leon Cooperman's portfolio in Q2 2026, its #27 holding.
  • Leon Cooperman first reported a position in DiaMedica Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • 88 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Cooperman Leon G's 13F filing for Q2 2026, filed 14 Aug 2026.